Market Place
Sourcing Support
Tonix Announces TNX-102 SL Presentations At PDDS 2024
23 Sep 2024 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Presented TNX-102 SL Data At MHSRS 2024
28 Aug 2024 //
GLOBENEWSWIRE
Novast labs`s Generics Cyclobenzaprine HCl Receives Approval in US
27 Aug 2024 //
FDA
Tonix Reports Q2 2024 Results And Operational Highlights
19 Aug 2024 //
GLOBENEWSWIRE
Macleods Pharma`s Generics Cyclobenzaprine HCl Receives Approval in US
22 Jul 2024 //
FDA
Tonix Reports Positive Pre-NDA Meeting With FDA For Fibromyalgia Drug
08 Jul 2024 //
GLOBENEWSWIRE
Tonix Announces Positive Pre-NDA Meeting With FDA For Tonmya™ In Fibromyalgia
20 Jun 2024 //
GLOBENEWSWIRE
Tonix Pharma Presents Poster On Tonmya™ For Fibromyalgia At EULAR 2024
17 Jun 2024 //
GLOBENEWSWIRE
Tonix`s Tonmya Shows Fibromyalgia-Associated Depression Activity
03 Jun 2024 //
GLOBENEWSWIRE
Tonix Presents TNX-102 SL Data At ASCP Annual Meeting
30 May 2024 //
GLOBENEWSWIRE
Tonix Launches New Phase III Study to Reconcile Mixed Fibromyalgia Data
22 Mar 2022 //
BIOSPACE
Enforcement Report - Week of September 8, 2021
08 Sep 2021 //
FDA
Neurana Pharmaceuticals to Present at Napa Pain Conference and PAIN Week
30 Aug 2021 //
PRNEWSWIRE
Neurana Pharmaceuticals Announces Top-Line Results from Tolperisone Phase 1 CNS
08 Dec 2020 //
PRNEWSWIRE
Tonix Pharmaceuticals Initiates Enrollment in Second Pivotal Phase 3 Study
03 Sep 2020 //
GLOBENEWSWIRE
Unichem Lab`s Generic Cyclobenzaprine Hydrochloride Receives Approval in U.S
09 Jul 2020 //
FDA
Unichem Labs gets USFDA nod to market muscle spasm tablets
06 Jul 2020 //
ECONOMICTIMES
Unichem Laboratories receives USFDA approval for Cyclobenzaprine HCI Tablets
06 Jul 2020 //
BUSINESS-STANDARD
Cyclobenzaprine Market (Impact Of Covid-19) Research Report 2020 Api Polpharma
05 May 2020 //
COLEOFDUTY
Tonix Achieves 50 Percent Enrollment in Phase 3 RELIEF Study of TNX-102 SL
24 Apr 2020 //
GLOBENEWSWIRE
Tonix Pharmaceuticals Announces Receipt of FDA Official Minutes from for Tonmya
26 Nov 2019 //
GLOBE NEWSWIRE
Tonix beings enrolment in Tonmya’s RECOVERY trial for PTSD
13 Mar 2019 //
DRUGDEVELOPMENT
Adare Licenses Cyclobenzaprine Hydrochloride In Portugal
08 Oct 2018 //
PRESS RELEASE
Shrink the Pt group, boost the efficacy: Tonix
22 Aug 2018 //
ENDPTS
Tonix crashes on PhIII PTSD failure, sending stock to the gutter
30 Jul 2018 //
ENDPTS
AMRIX® (cyclobenzaprine HCl ER): Adare Pharmaceuticals, Inc. & Teva Pharmaceuticals GmBH v. Inventia Healthcare Pvt Ltd.
23 Jul 2018 //
PATENT LITIGATION
Tonix Pharmaceuticals Receives FT Designation from FDA for TNX-102 SL in Alz
16 Jul 2018 //
GLOBENEWSWIRE
Enforcement Report - Week of February 28, 2018
28 Feb 2018 //
FDA
Rubicon Res Generic Cyclobenzaprine Hydrochloride Receives Approval In US
03 Jun 2017 //
FDA
Natural product analysis offers insight on compound discovery trends
11 May 2017 //
CEN
Tonix could get 2019 nod for breakthrough-badged PTSD therapy: analysts
20 Apr 2017 //
FIERCE BIOTECH
Tonix Pharmaceuticals to Host Posttraumatic Stress Disorder Awareness Day
19 Oct 2016 //
GLOBENEWSWIRE
Tonix enrolls patients for phase 2 AtEase clinical trial
23 Dec 2015 //
PBR
Tonix Pharma, U.S. Defense Department partner on PTSD drug
07 Dec 2015 //
REUTERS
